Lung cancer
Conditions
Interventions
Sponsors
West China hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) male or female aged 18 or above, 75 or below, with a life expectancy of 12 weeks or more; 2) pathological or cytological diagnosis of stage IIIB-IV non-small cell lung cancer; 3) previous failure to receive systemic anti-tumor treatment; 4) subjects are willing to take effective contraceptive measures without pregnancy plan in the next 6 months.
Exclusion criteria
Exclusion criteria: 1) previously received systemic anti-tumor treatment; 2) pregnant and lactating women and planned pregnancy patients during the study; 3) the patient has other systemic diseases that are difficult to control (such as serious heart diseases); 4) the investigator considers it inappropriate to participate in the study for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prognostic markers of immunotherapy for lung cancer;Potential mechanisms of drug resistance in lung cancer immunotherapy; | — |
Countries
China
Contacts
Public ContactTian Panwen
West China hospital, Sichuan University
Outcome results
None listed